Clinical implications of longitudinally assessed uric acid in heart failure
Nutrition, Metabolism and Cardiovascular Diseases · 2025
DOI: 10.1016/j.numecd.2024.103829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Liyan Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of…. Hauptthemen laut MEDLINE: Uric Acid, Heart Failure, Hyperuricemia. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Beijing Natural Science Foundation.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND AND AIMS: Numerous studies have evaluated the association between baseline uric acid (UA) and heart failure (HF) outcomes. The impact of longitudinal UA on HF survival remains unknown. We aim to investigate the association between different parameterizations of longitudinal UA measurements and survival outcomes in HF patients. METHODS AND RESULTS: We retrospectively included patients hospitalized for HF with multiple repeated UA measurements. Joint models were fitted to assess the longitudinal association between UA and outcomes of all-cause and cardiovascular (CV) death. The study included 1596 patients (mean age 54 years, 26.9 % women) with 7875 UA measurements. During a median follow-up of 34.7 months, 330 all-cause deaths occurred, among them 280 of CV causes. After adjusting for clinically relevant covariates, every doubling of UA at any time led to a 5.14-fold increase of all-cause death risk (95 % confidence interval [CI] 3.79-8.29) and a 4.56-fold increase of CV death risk (95 % CI 2.96-8.29) for men; for women, the corresponding hazard ratios were 4.47 for all-cause death (95 % CI 3.02-7.40) and 4.93 for CV death (95 % CI 2.78-8.58). The increase in slope and area under the UA trajectory were additionally associated with a higher risk of all-cause and CV death in both genders. All the associations remained consistent after adjusting for repeatedly measured renal function and across the ejection fraction phenotypes. CONCLUSION: The longitudinally measured UA and its derived parameterizations are strong prognostic factors in hospitalized HF patients, independent of clinically relevant confounders and repeatedly assessed renal function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Beijin…
Förderung
- Beijing Natural Science Foundation
Zitieren
APA
Huang, L., He, C., Li, X., Xin, A., Zhou, P., Han, H., Feng, J., Zhao, X., Zhai, M., Zhang, J., & Zhang, Y. (2025). Clinical implications of longitudinally assessed uric acid in heart failure. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2024.103829
Vancouver
Huang L, He C, Li X, Xin A, Zhou P, Han H, et al. Clinical implications of longitudinally assessed uric acid in heart failure. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2024.103829
BibTeX
@article{Huang2025,
author = {Huang, Liyan and He, Chunhui and Li, Xinqing and Xin, Anran and Zhou, Ping and Han, Huiqiao and Feng, Jiayu and Zhao, Xuemei and Zhai, Mei and Zhang, Jian and Zhang, Yuhui},
title = {Clinical implications of longitudinally assessed uric acid in heart failure},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2025},
doi = {10.1016/j.numecd.2024.103829}
}
EUVIMED